Life Sciences Training Course Calendar

Back to details

Training format

Topic

Our Life Sciences calendar for the next 12 months:

Live online Classroom 2026 2027
Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products

Animal Health 6

A Practical Approach to Veterinary Vaccine Development and Registration in the EU

Animal Health 9-10 22-23

A Practical Guide to Producing and Maintaining the PSMF & Annexes

Vigilance 5 15

A Practical Guide to Writing Risk Management Plans (RMPs)

Vigilance 19 18

A Practical Introduction to Good Clinical Practice (GCP)

New for 2027

GxP 14 5

A Practical Overview of Pre-Filled Syringes

Medical Devices 24-25

AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects

Artificial Intelligence (AI) in Life Sciences 10

AI in Healthcare: Governance, Risk & Strategic Adoption

New for 2027

Artificial Intelligence (AI) in Life Sciences 9 21

AI in Pharmacovigilance

Artificial Intelligence (AI) in Life Sciences 17

APIs in Focus: Understanding ICH, GMP and Supply Chain Excellence

GxP 28-29 20-21

Additional Risk Minimization Measures (aRMMs) and Their Effectiveness

Vigilance 2 15

Advanced GMP & GDP Auditor Masterclass

New for 2027

GxP 12-14 12-14

Advanced Pharmacovigilance: From Performing Successful Due Diligence to Benefit-Risk Assessments – What to Consider

Vigilance 1-3 20-24

Advanced Veterinary Pharmacovigilance

Animal Health 10-11

An Essential Overview of Medical Information

Regulatory Affairs 21

An Introduction to Ethylene Oxide (EO) Sterilization for Medical Devices

Medical Devices 13

An Introduction to Human Factors for Pharmaceutical and Medical Device Professionals

Medical Devices 7

An Introduction to the Design and Development of Medical Devices and Device-Drug Combination (DDC) Products

Medical Devices 28-29

An Overview of EU and UK Regulatory Affairs

Regulatory Affairs 3-4 20-21

Animal Feed and Feed Additive Registration in China and Thailand

Animal Health 15 21

Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions

New for 2027

Regulatory Affairs 9

Behavioural Risk Management in Clinical Trials

New for 2027

Clinical Research 15 19

Best Practices for Supplier Qualification in Life Science

Medical Devices 26-27

Biological Evaluation of Medical Devices

Medical Devices 20-21 1-2

Biosimilars

Biopharma 15-16 20-21

Biotechnology for the Non-Biotechnologist

Biopharma 9-11

CAPA (Corrective and Preventative Action)

Regulatory Affairs 14

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

GxP 22-23 18-19

Cleaning Validation - Best Practice in Pharmaceuticals

GxP 22-23

Cleanroom Requirements for Medical Device Manufacturers

Medical Devices 22 20

Clinical & Post-Marketing Safety

Vigilance 10-11

Clinical Evaluation of Medical Device Software and Software as a Medical Device

Medical Devices 21 7

Clinical Overview and Clinical Summary: Creating Effective Marketing Authorisation Applications

Regulatory Affairs 3-4 29-30

Clinical Quality Management Systems (CQMS): A Practical Guide to Inspection Readiness

Clinical Research 15-16 16-17

Clinical Research Project Management

Leadership & Management for Life Sciences 28-30 20-22

Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets

Commercial Contracts 12

Clinical Trial Monitoring

Clinical Research 17-18

Clinical Trial Regulatory Requirements

Clinical Research 1-2 23-24

Clinical Trials in the MENA Region

New for 2027

Clinical Research 26

Competition Law for the Pharmaceutical Industry

Commercial Contracts 26 8

Conflict Management for Pharmaceutical Executives

New for 2027

Leadership & Management for Life Sciences 3-4 27-28

Cosmetovigilance

Cosmetics 10-11 17-18

Data Integrity and Document Management

Medical Devices 21

Data-Driven Process Control: Statistical Process Control (SPC) Tools for Quality, Stability, and Performance

New for 2027

GxP 24-25 27-28

Dealing With Scientific Journal Reviewers: From Comments to Resubmission

New for 2026

Medical Devices 1

Development of Combination Products: Critical Interactions

GxP 8-9 15-16

Difficult Conversations and Influence in Regulated Environments

Leadership & Management for Life Sciences 26 18

Drafting Commercial Contracts for the Pharmaceutical Industry

Commercial Contracts 19-20

EU Pharmaceutical Regulations and Strategy

Regulatory Affairs 1-2 4-5

EU Proposed Pharmaceutical Legislation Changes

Regulatory Affairs 18 7

Effective Technical Writing & Editing

Medical Writing 14

Effective Technology Transfer

GxP 8-9 7-8

FDA Approval Process for Medical Devices

Medical Devices 1-2 24-25

Finance for Non-Financial Leaders in the Pharmaceutical Industry

New for 2027

Leadership & Management for Life Sciences 13-14

GMP Advanced Masterclass for Pharmaceutical and Biotechnology Industries

New for 2027

GxP 7-9

GMP Principles in Vaccine Manufacturing

GxP 15-16

Good Distribution Practices of Pharmaceuticals and APIs

GxP 20-21

How the Pharmaceutical and Biotech Industries Work: From Molecule to Market

Regulatory Affairs 11 27

ICH Q12: Advanced Pharmaceutical Product Lifecycle Management in Practice

New for 2027

GxP 18-19 7-8

ICH Q9(R1) Quality Risk Management (QRM)

Updated for 2027

GxP 24

Integrating AI into the GMP Environment

New for 2027

Artificial Intelligence (AI) in Life Sciences 7

Introduction to Veterinary Pharmacovigilance

Animal Health 8-9 15-16

Literature Searching in Drug Safety

Vigilance 13-14

MBA Frameworks for Strategic Thinking in Pharma & Biopharma

Leadership & Management for Life Sciences 22-23 20-21

Managing Service Providers including CRO and CMOs oversight to comply with ICH GCP R3

Animal Health 12-13 14-15

Masterclass: Market Authorisation of AI-enabled Medical Devices

Artificial Intelligence (AI) in Life Sciences 28-30

Mastering CTD Submissions in the MENA Region

Regulatory Affairs 25

Mastering Computer System Validation

GxP 16-17

Measuring Performance in Clinical Research Management

Clinical Research 17

Medical Device Cybersecurity and Regulatory Compliance

Medical Devices 18-19 30-1

Medical Device Regulation in the Eurasian Union, Russia and the CIS

Medical Devices 29-30

Medical Device Regulations in Asia-Pacific Markets

Medical Devices 2-3 15-16

Medical Device Regulations in the Middle East and North Africa

Medical Devices 17-18

Medical Device Software: Complying with the EU MDR, EU IVDR & FDA Regulations

Medical Devices 25-29 21-25

Medical Device Studies: Regulatory Requirements and Adverse Event Reporting

Medical Devices 16-17 16-17

Medical Writing for Medical Devices

Medical Devices 16-17

Mergers & Acquisitions and Partnerships in the Pharmaceutical Sector

New for 2026

Leadership & Management for Life Sciences 25-27 23-25

Metered Dose Inhalers (MDI) Technology in the 2020s and Beyond

Medical Devices 26-27 6-7

Microbiomics in Clinical Trials

New for 2027

Clinical Research 25 17

Modern Agile Leadership for Pharma and Biopharma Professionals: Adapting to a Changing Workplace

Leadership & Management for Life Sciences 10-11

Molecular Biology from Fundamentals to the Latest Applications

Biopharma 19-20 7-8

Navigating EU Product Classification: Foods, Supplements & Herbal Medicines Masterclass

Updated for 2027

Regulatory Affairs 10

Negotiation Skills for Pharma Professionals: Cross-Border, Virtual and AI Enabled Dealmaking

New for 2027

Leadership, Strategy & Negotiation 20-21

New EU GMP Annex 1: Compliant Sterile Medicinal Products

GxP 28-30 4-6

Orphan Drug Regulatory Masterclass: EU & US Insights

Regulatory Affairs 3 28

Pharma Facility Project Management: Delivering GMP‑Compliant Sites On Time and Within Budget

New for 2027

GxP 8-9 15-16

Pharmaceutical Development of ATMPs

GxP 17-18 27-28

Pharmaceutical Packaging Essentials: From Regulatory Compliance to Market Success

GxP 17-19 21-23

Pharmaceutical Regulatory Affairs in Asia

Regulatory Affairs 3-5 19-21

Pharmaceutical Regulatory Affairs in China

Regulatory Affairs 25-26 19-20

Pharmaceutical Regulatory Affairs in Russia, Eurasian Union and the CIS

Regulatory Affairs 4-5 29-30

Pharmaceutical Regulatory Affairs in the Middle East

Regulatory Affairs 12-13 19-20

Pharmaceutical Regulatory Affairs in the Middle East and North Africa

Regulatory Affairs 7-9

Pharmacovigilance Aspects of Licensing Agreements

Vigilance 9 30

Pharmacovigilance QMS & Inspection Preparation

Vigilance 26-27 7-8

Pharmacovigilance: An Overview of Drug Safety from Safety Collection to Regulatory Inspection

Vigilance 29 4

Positive Persuading and Influencing Skills for Pharma Professionals

Leadership & Management for Life Sciences 26-27

Post-Market Surveillance and Vigilance of Software as a Medical Device (SaMD) and Medical Device Software (MDSW)

New for 2027

Medical Devices 15-16 4-5

Practical Implementation of GCP in Veterinary Field Studies

Animal Health 24-25 20-21 13-14

Practical Risk Management in Clinical Research and Trials

Clinical Research 23 5

Preparing for GCP Inspections: Key Expectations under ICH GCP E6(R3), EU CTR and Current Regulatory Thinking

Clinical Research 25

Process Validation for Medical Devices

Medical Devices 10-11

Process Validation with Qualification

GxP 14-15

Project Management for Pharma Professionals

Leadership & Management for Life Sciences 30-1 13-14

Project Management for Regulatory Affairs Professionals

New for 2027

Leadership & Management for Life Sciences 19-20 7-8

Protein Engineering for Pharmaceutical Biotechnology

New for 2027

Biopharma 2-3 21-22

Root Cause Analysis and Critical Thinking

Leadership & Management for Life Sciences 24

Signal Detection and Regulatory Expectations

Vigilance 25-26 29-30

Smart Packaging and Electronic Patient Information

Medical Devices 20

Smarter Selling Through Market Research: Building Better Commercial Decisions in Life Sciences

New for 2027

Leadership & Management for Life Sciences 24 13

Stability Testing of Pharmaceuticals and Biopharmaceuticals

GxP 19-21

Sterilization of Medical Devices

Medical Devices 22-23 11-12

Successful Medical Writing – from Protocol to CTD

Medical Writing 11-12 21-22

Sustainable Product Design for MedTech Engineers and Developers

Medical Devices 6-7

The 2024 EU AI Act

Artificial Intelligence (AI) in Life Sciences 22

The Common Technical Document

GxP 13-14 20-21

The FDA Drug Approval Process

Regulatory Affairs 22-23 23-24

The Future of Bioplastics in the Medical Industry

New for 2027

Medical Devices 10 28

The Future of Manufacturing: 3D Printing for Medical Devices

New for 2027

Medical Devices 16

The Pharma Mini MBA

Leadership & Management for Life Sciences 19-21

The Principles & Applications of CRISPR

New for 2027

Biopharma 22 6

The Regulatory Requirements on Nitrosamines in the Pharmaceutical Industry

Regulatory Affairs 19-20 11-12

Thinking Beyond Traditional GMP

GxP 9-10 15-16

UK Conformity Assessed (UKCA) Marking for Medical Devices

Medical Devices 14 20

US FDA - Understanding Key Factors When Working with the FDA

Biopharma 19 7

Understanding Pharmacovigilance Regulations in China

New for 2027

Vigilance 27 11

Unique Device Identification (UDI) and Labelling for Medical Device Manufacturers

Medical Devices 7

Variations to Marketing Authorisations

Regulatory Affairs 14-15

Veterinary Pharmaceutical Submissions in the EU

Animal Health 17-18

Writing Inspection-Ready SOPs: Best Practice for Compliance and Control

Regulatory Affairs 26 6